Murine lymphoid procoagulant activity induced by bacterial lipopolysaccharide and immune complexes is a monocyte prothrombinase by Schwartz, BS et al.
MURINE  LYMPHOID  PROCOAGULANT  ACTIVITY  INDUCED 
BY  BACTERIAL  LIPOPOLYSACCHARIDE  AND 
IMMUNE  COMPLEXES  IS  A  MONOCYTE  PROTHROMBINASE* 
BY BRADFORD  S.  SCHWARTZ,:~ GARY  A.  LEVY,§ DARYL  S.  FAIR, AND 
THOMAS  S.  EDGINGTON 
From the Department  of Molecular Immunology, Research Institute of Scrzpps Clinic, 
La Jolla, California 92037 
Cells of the monocyte-macrophage series can be induced to one or more derivative 
states  by  selected  biological  encounters  (1,  2).  Directed  by  the  stimulus,  diverse 
responses are observed, among which phagocytosis (3),  bactericidal activity (4),  and 
secretion of biologically active products into the extracellular milieu are well docu- 
mented  (5).  The  immature  circulating  and  migratory  members of this  series,  i.e., 
monocytes,  are  immobilized  at  sites  of  classical  cellular  immune  reactions  and 
contribute  to  the  features  of these  and  other  immunologic  tissue  lesions.  Effector 
molecules, or monokines, are a diverse and functionally heterogeneous group. Factors 
such  as  interleukin  1,  colony-stimulating  factor,  and  proteolytic  enzymes  may  be 
specifically induced  and  released.  These  products,  which  can  induce  responses  in 
selected cells (6,  7), degrade the extracellular matrix (8, 9), contribute to the charac- 
teristics of immune and nonimmune tissue lesions, and proteolytically activate plasma 
proteins of the coagulation, fibrinolytic, and complement pathways (10,  1 t). 
Tissue lesions mediated by cellular immune responses usually exhibit  fibrin depo- 
sition. Independently, monocytes have been implicated as major effector cells in these 
lesions (12,  13). We have recently described the requirements for cellular collaboration 
in the induction  of lymphoid procoagulant activity (PCA) a after exposure of cells to 
bacterial lipopolysaccharide (LPS) or antigen/antibody complexes (Ag/Ab) in rnurine 
splenic and peripheral blood mononuclear cells  (PBM)  (14,  15). Murine  peripheral 
blood and splenic PCA were established as products of monocytes and macrophages, 
respectively; however, unidirectional instructions from stimulus-triggered lymphocytes 
were required  to rapidly express the monocyte effector molecules in high concentra- 
tion. Cellular collaboration for the response to LPS require major histocompatibility 
complex  compatibility  at  I-A  (16).  Using  similar  stimuli,  induced  human  PBM 
initiate  the  extrinsic  plasma  coagulation  cascade  by  producing  membrane-bound 
tissue-factor activity  (17-21).  The significant  role that  cellular surfaces play in  the 
local deposition of fibrin is exemplified by studies  (22) of the platelet membrane as a 
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focal  point  for  assembly  of soluble  coagulation  proteins  into  complexes  that  are 
kinetically >100,000-fold  more  efficient  in  thrombin  generation  than  the  soluble 
proteins  alone.  Indeed,  the  formation  of activated  factor X  (Xa)  on  phospholipid 
vesicles may depend on a  similar membrane surface complex  (23).  Whether similar 
membrane assembly mechanisms are involved in the collaboratively induced mono- 
cyte PCA responses is not known. In the present report we describe the first exploration 
of this topic and characterize the inducible murine monocyte PCA. This is a  clearly 
distinctive molecule or set of molecules that  differs from  the tissue factor activity of 
induced human  monocytes, in that  it proteolytically activates prothrombin  directly 
to  thrombin  or  a  functional  thrombin-like  enzyme  in  the  absence  of the  classical 
precursors, namely factors VII or X.  This  appears  to  represent  a  new  pathway  by 
which selected responses of lymphoid cells may recruit the coagulation pathways in 
the mediation of inflammatory responses. 
Materials and  Methods 
Mice.  C3H male mice of 8-12 wk of age were provided by the Research Institute of Scripps 
Clinic breeding facility and maintained with water and chow ad lib. 
Cells.  Peripheral blood was collected from the axillary vein into heparinized capillary tubes 
(Scientific Products Div., American Hospital Supply Corp., McGaw Park, IL), diluted into 3 
vol of incomplete medium (RPMI 1640 containing 100 U/ml penicillin, 50/lg/ml streptomycin, 
and 2 mM glutamine [Gibco Laboratories, Grand Island Biological Co., Grand Island, NY]), 
and  centrifuged over Ficoll-Hypaque (Sigma Chemical Co.,  St.  Louis, MO  and  Winthrop 
Laboratories, Menlo Park, CA, respectively), density 1.074  gm/ml, at  1,400 g  for  10 min at 
20°C. The cells at the interface were collected, washed twice with incomplete medium, and 
resuspended at  1 ×  106 celts/ml in complete medium consisting of 10% heat-inactivated fetal 
calf serum in incomplete medium. These PBM were >98% mononuclear by cytologic exami- 
nation of Wright-Giemsa stained preparations, and >99% excluded trypan blue. 
Whole PBM  were separated by adherence as previously described (15)  into  lymphocyte- 
enriched (lymphocyte) and monocyte-enriched (monoeyte) populations. 1 ml of 1 ×  106 PBM 
in  complete medium  was incubated  in  16-mm  flat-bottomed plastic culture wells (24-well; 
Costar, Data Packaging, Cambridge, MA) for 24 h at 37°C in 6% COz-air. Nonadherent cells 
were decanted with the medium and washed.  1 ml of Puck's saline A  (Gibco Laboratories) 
containing 3 mM EDTA and 3% bovine serum albumin (Calbiochem-Behring Corp., American 
Hoechst Corp., San Diego, CA) was added to the adherent cells, and the plates were rotated on 
a  gyrotory platform at  150  rpm  at  22°C  for  30  min.  The  detached  monocytes were  then 
recovered, washed, and suspended in complete medium. Recovery of lymphocytes was 83  zt: 
4°70. More than 98%  of cells appeared cytologically to be lymphocytes and were negative for 
nonspecific esterase. Recovery of monocytes was 75 +- 5%; cytologically  >98% were of monocyte 
morphology and positive for nonspeeific esterase (24). 
In Vitro PCA Response.  Cells were incubated at 1 ×  106 cells/ml at 37°C, 6% CO2 in 16-mm 
fiat bottomed wells in the presence or absence of designated stimuli for periods up to 24 h, as 
indicated. Complete medium and  incomplete medium were equivalent in support of tested 
functions through 6 h, but for longer cultures complete medium was used. All materials added 
to cells were first sterilized by filtration through 0.22/.tm filters (Millipore Corp., Bedford, MA) 
or by ultraviolet radiation. 
Proteins.  Soluble Ag/Ab complexes were prepared from affinity-purified goat antibodies to 
human  albumin as previously described  (15).  Ag/Ab and  culture media were  free of LPS 
contamination  (<1  ng/ml)  by  heat-inactivation  (25),  limulus  amebocyte  lysate  (E-toxate, 
Sigma Chemical Co.) and mouse lethality assays (26). 
Human  factor X  and prothrombin were isolated from Cohn Fraction III (kindly provided 
by Dr.  William Brockway, Cutter  Laboratories) by sequential chromatography on  DEAE- 
cellulose, heparin-agarose, and homoarginine-agarose as described previously (27,  28).  Benz- 
amidine (2 mM)  (Aldrich Chemical Co., Milwaukee, WI) and NaN3  (0.02%)  were included 1466  INDUCIBLE  MONOCYTE  PROTHROMBINASE 
throughout the isolations. Both factor X  and prothrombin were devoid of detectable contami- 
nants  by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)  (29).  Pro- 
thrombin was radioiodinated by the glucose oxidase method (Enzymobeads, Bio-Rad Labora- 
tories, Richmond, CA) to asp act of 4.3-7.2/zCi/#g. 
Human  factor X  was activated following the procedure of DiScipio et al.  (30).  20  mg of 
factor X  (5 mg/ml), equilibrated in 0.05 M Tris/HC1, pH 7.8, containing 0.15 M  NaCI, 0.02% 
NaN3 was activated with purified Russell's viper venom (the generous gift of Dr. W. Kisiel and 
Dr. E. W. Davie) at an enzyme/substrate weight ratio of l:l,000. The reaction was initiated by 
adding dry CaC12 to a final concentration of 5 mM and incubated at 37°C for 20 min. After 
terminating the reaction by addition of EDTA, the sample was applied to a Sephadex G-100 
column (2.5 ×  90 cm) equilibrated in PBS (0.01  M  phosphate, pH 6.0, 0.14 M  NaC1),  1 mM 
benzamidine, 0.02%  NAN3. The activated preparation was rechromatographed over the same 
column to ensure separation from unactivated factor X  and was judged pure by SDS-PAGE 
using both reduced and unreduced conditions. 
Human fibrinogen was isolated from fresh human plasma anticoagulated with acid-citrate- 
dextrose by differential precipitation according to  Doolittle et  al.  (31).  The  fibrinogen was 
exhaustively  dialyzed against  0.15  M  NaCI,  0.05  M  Tris/HC1  pH  7.2  and  clarified  by 
ultracentrifugation at  100,000 g for 2 h. The purified protein gave the appropriate molecular 
weight band(s) on SDS-PAGE under both reduced and unreduced conditions and was >97% 
clottable by a-thrombin. LPS  (Escherichia coh, 011 I:B4, butanol-extracted) was the generous 
gift of Dr. David Morrison (Emory University, Atlanta, GA). 
PCA Assays.  Samples were assayed for PCA by their ability to accelerate the spontaneous 
clotting time of normal recalcified human  platelet-poor plasma as previously described (14, 
15). Results  were  quantitated  by  comparison  to  serial  dilutions of standard  rabbit  brain 
thromboplastin  (Dade  Div., American Hospital Supply Co.,  Miami, FL).  Human  plasmas 
deficient in specific clotting factors (George King Biological Co., Overland Park, KS) were also 
used  as  substrate  in  the  clotting assay  in  place of normal  human  plasma.  To  determine 
functional prothrombin cleavage, 0.05  ml of fibrinogen (4 mg/ml) was added to 0.05  ml of 
prothrombin (0.16 mg/ml), and 0.1 ml of cellular sample was added. After addition of 0.1 ml 
of 25  mM  CaCI2,  the  interval  for  visual  appearance  of fibrin  at  37°C  was  determined. 
Subcellular analyses used the supernatant and pellet from centrifugation at  100,000 g for 1 h 
of l0  T monocytes that had been disrupted with a Dounce homogenizer. 
Prothrombin Cleavage Assay.  Samples (0.02-0.05-ml)  to be tested for prothrombin cleaving 
activity were added to 0.01  ml of 100 nM 12~I-prothrombin and 0.01  ml of 25 mM CaC12 and 
incubated at 37°C  for 30 rain. The reaction was terminated by  1% SDS, 1% EDTA, and the 
products analyzed by electrophoresis in 10% polyacrylamide,  0.1% SDS in tube gels (28), which 
were  subsequently  sliced  at  2-mm  intervals and  analyzed  for  12sI. Alternatively, reaction 
products were electrophoresed in  10% polyacrylamide, 0.1%  SDS slab gels (32),  fixed, dried, 
and quantitated by autoradiography and soft laser densitometry (Zieneh, Biomedical Instru- 
ments, Chicago, IL). 
Calcium Requirement and Protease Inhibition  Studies.  Controls and  samples were  assayed for 
prothrombinase activity in the absence of added calcium and in the presence of 10 mM EDTA. 
Alternately, cell homogenates (0.04 ml) containing PCA were exposed to serial concentrations 
of diisopropylfluorophosphate (DFP) for 15 min at 22°C then assayed by the addition of 12sI- 
prothrombin  (0.01  ml  100  nM)  and  CaCI2  (0.01  ml  of 25  mM)  for an  additional 30  min, 
followed by SDS-PAGE and autoradiographic analysis. 
Kinetics and Influence of Cell Number on  t2SLProthrombin Cleavage by Stimulated Monocytes.  For 
kinetic studies 0.05 ml of cellular homogenates (2 ×  l0  s Ag/Ab or LPS-stimulated PBM/ml 
tris-huffered saline [TBS])  were incubated at 37°C  with 0.01  ml 125I-prothrombin (100  nM) 
(0.045  potential U  thrombin), 0.01  ml hirudin (0.2 U)  (Sigma Chemical Co.), 0.02 ml CaCI2 
(25 mM). At selected intervals, the reaction was stopped by the addition of EDTA and SDS, 
and 125I-prothrombin cleavage quantitated by SDS-PAGE. Alternately, prothrombin cleavage 
by homogenates of serial concentrations of monocytes were quantitated as above. Hirudin was 
used  to specifically and  rapidly inhibit  the  thrombin  products, thus  eliminating reciprocal 
precursor (prothrombin and intermediates) cleavage by product (thrombin). 
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with LPS or Ag/Ab, washed twice with  1.0 ml, and resuspended  in 0.5 ml of buffer consisting 
of 0.14 M  NaCI, 0.02  M  Hepes at selected pH from 6.0 to 8.5. Cell homogenate  (0.04 ml), 25 
mM CaC12 (0.01  ml in buffer of same pH), and laSI-prothrombin  (0.01  ml) were combined at 
37°C  for  30  min.  Control  incubations  contained  appropriate  pH  buffer  in  place  of cell 
homogenate.  The  pH  of each  reaction  was  determined  before  the  reaction  mixtures  were 
analyzed  for  125I-prothrombin  cleavage by  SDS-PAGE  and  autoradiography.  Temperature 
dependence of the reaction was analyzed at 4,  15, 22, 37, 50, and  70°C. 
Analysis  for Presence of Zymogen  or Inhibitors.  1 ×  106  LPS- or Ag/Ab-triggered PBM  were 
combined with 0-4 ×  106 untriggered PBM in a  final volume of 1 ml of TBS. The cells were 
washed twice in  1 ml and resuspended  in 0.5 ml of TBS, disrupted as described above, and a 
0.025 ml aliquot of homogenate assayed for 125I-prothrombin-cleaving activity. 
Plasminogen  Activator.  Homogenates of 1-6  ×  106 PBM  in 0.5  ml TBS were analyzed  for 
plasminogen activator by the 125I-fibrin  plate assay (10,  33). 
Results 
Murine PBM in the basal states, i.e., when examined immediately upon isolation, 
expressed little PCA. In contrast, in vitro cultivation of these cells for 6 h in complete 
or incomplete medium resulted in a variable but limited nonspecific increase of PCA 
(50-75  mU/106 cells).  This was equivalent  whether  the cells were dispersed  over a 
2-cm  2 surface area of a  plastic culture plate or incubated in a  small settled pellet of 
n0.1  cm  2 in a  12 ×  75 tube, suggesting that attachment is not a significant variable. 
Incubation  of PBM  with  100  #g/ml soluble Ag/Ab or  10/zg/ml  LPS  in  complete 
medium induced a 4-fold increase in PCA as compared with control PBM incubated 
in  the absence of stimuli  (Table I), or a  20-24-fold  increase relative to cells in  the 
basal state.  PCA was evident  when  intact  viable cells  (>98%  exclude trypan blue) 
were assayed, but was about fivefold greater when cells were disrupted before assay, 
indicating that only ~20% of the total cellular PCA was expressed on the surface of 
viable cells. 
Requirements of the cellular PCA for known coagulation factors was investigated 
by substitution of factor-deficient plasmas for normal plasma in the PCA assay (Table 
II). Prolongation of the clotting time in plasma deficient in a known factor indicated 
that the deficient  factor was required  for the cellular PCA to maximally accelerate 
coagulation.  The  quantity  of PCA  induced  by  Ag/Ab  or  LPS  was  similar,  and 
TABLE  I 
Murine  PBM Demonstrate Increased Content of Procoagulant Activity upon 




Intact viable cells  Cell homogenate 
Clotting  PCA  Clotting  PCA 
time  S  times 
s  mU/lO e cells  s  mU/lO e cells 
TBS  58 ± 4  91 ±  17  42 ±  3  388 ±  16 
LPS§  46 +  3  270 ±  21  30 ±  1  1590 +  31 
Ag/Ab  u  47 ±  4  255 :t: 26  30 ±  2  1575 ±  56 
* 10  s PBM incubated with indicated stimulus at 37 ° for 6 h, washed twice in 
1 ml TBS, and resuspended  in 0.5 ml TBS, then assayed for PCA as described 
in Materials and Methods. 
:]: One-stage clotting assay with normal human plasma. 
§ iO #g/ml. 
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TASL~ II 
Inducible Murine PCA Differentially Supports Clotting In Human Factor-deficient Plasma 
Cell stimulus 
10  n PBM*  NHP$ 
Proeoagulant activity:(mU) plasma deficient in:§ 
XlI  VllI  VII  X  V  II  +Iit1 
S  S  $  $  $  $  $  S 
LPS  31  30  30  30  31  30  >120  31 
(1450)  (1500)  (1520)  (1560)  (1480)  (1520)  (<4)  (1500) 
Ag/Ab  30  30  31  30  30  30  >120  31 
(1530)  (1520)  (1420)  (1600)  (1550)  (1530)  (<4)  (1470) 
* 10  n PBM incubated with indicated stimulus for 6 h at 37°C, washed twice with and resuspended in 0.5 
ml TBS, subjected to freeze-thaw sonieation, and assayed using the indicated factor-deficient human 
plasmas. 
$ Normal human plasma. 
§ One-stage  clotting time with human plasma deficient in the indicated plasma coagulation factor. Values 
are the mean of three determinations. 
[1 Prothrombin-deficient plasma to which 80 #g/ml purified prothrombln was added before assay. 
plasmas  genetically  deficient  in  factors  XlI,  VIII,  VII,  X,  or  V  supported  the 
coagulation  response  as  well  as  normal  pooled  plasma,  indicating  that  there  is  no 
requirement  for these factors (Table II). Plasma deficient in prothrombin  (factor II) 
did not clot with the addition  of either control or stimulated cells. The addition  of 
physiologic concentrations of purified prothrombin  (80 #g/ml)  to factor II-deficient 
plasma restored the cofactor capacity of this deficient plasma. 
Prothrombin  Activation.  The above data suggested the direct use of prothrombin to 
produce active thrombin or thrombinlike derivatives. To examine the validity of this 
hypothesis, ceils or cellular homogenates were incubated with ~2~I-prothrombin for 30 
min at 37°C, the reactions terminated by addition  of SDS and EDTA (the latter to 
release the prothrombin from the cell membranes), and cleavage analyzed by SDS- 
PAGE  followed by autoradiographic  display.  In Fig.  1 (lower panel)  a  single  high 
molecular weight  species of intact  125I-prothrombin was  observed  after incubation 
with buffer and calcium alone, whereas addition of human factor Xa, the physiologic 
activator of prothrombin,  in  the  presence  of calcium  produced  cleavage  products 
corresponding to known derivatives of prothrombin.  Incubation of 125I-prothrombin 
with cellular homogenates from stimulated PBM also generated similar products (Fig. 
1, top panel), consistent with the direct cleavage of prothrombin by the cellular PCA. 
On the other hand, after addition of freshly isolated basal PBM to 125I-prothrombin 
in the presence of calcium, only intact prothrombin was observed (Fig.  1, top panel), 
indicating that the cellular prothrombinase was not present in an active form. 
To determine if the cleavage ofprothrombin by monocyte PCA yielded a functional 
thrombinlike  product,  cellular  homogenates  were  added  to  a  mixture  of purified 
prothrombin  and  fibrinogen.  Clot  formation  was  monitored  after  the  addition  of 
calcium chloride (8 mM final concentration). Ag/Ab- or LPS-stimulated PBM readily 
induced the formation of a  fibrin clot  (Table III). Exclusion of any one of the assay 
components completely prevented the response, indicating that fibrin formation did 
not  result  from  a  direct  conversion  of fibrinogen  to  fibrin  by  PCA,  but  that  a 
prothrombin product was required. 
Divalent  Cation  Requirement.  PCA-induced  clot  formation did  not  proceed  in  the 










/  i 
~ ,"  ,  i  i~r ---.  .......  ,  ,  ~,*- 
80-  40-  / '  //"  "'  "~  j 
0 ~ ~"  lb  l's  2'0  2'5  3'o  3'5  4'0  4'5  5'0  5'6  6'0 
Gel Slice 
FzG.  l.  Cleavage of 126I-prothrombin  by human factor Xa and inducible murine prothrombinase. 
I25I-prothrombin 0.01 ml of (100 nM) was incubated with CaC12 (0.01 ml 25 raM) and 0.05 ml of 
test sample for 30 min at 37°C. SDS,/~-mercaptoethanol, and EDTA were added, and the samples 
applied to SDS-10%  polyacrylamide tube ~els. After electrophoresis, gels were cut into 2-ram slices 
125  and counted for radioactivity. Top panel:  I-prothrombin incubated with: CaCI2 and homogenates 
from 106 unstimulated cells (- - -); EDTA (30 mM) and homogenates from  106 Ag/Ab-stimulated 
cells  ( ..... );  CaCI2  and  homogenates from  106 Ag/Ab-stimulated cells  (  ).  Bottom  panel: 
1251-prothrombin incubated with: CaC12 and TBS (- - -); CaCI2 and 150 ng/ml (final concentration) 
purified human factor Xa (  ). 
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TABLE  III 
Inducible Monocyte Prothrombinase Forms Functional Thrombin 
from Prothrombin 
106 PBM incubated  Fibrino-  Pro-  CaCI2 
with*  gen  thrombin  25 mM  Clotting time 
4 mg/ml  i00/tg/ml 
s 
TBS  +  +  +  >420 
LPS or Ag/Ab  +  +  +  46 
LPS or Ag/Ab  +  0  +  >420 
LPS or Ag/Ab  0  +  +  >420 
LPS or Ag/Ab  +  +  0  >420 
* 0.1 ml of cell homogenate was tested in the assay mixture, composed of 0.05 
ml fibrinogen, 0.05 ml prothrombin, 0. [ ml CaCI2. Final volume was adjusted 
to 0.3 ml with TBS. 
by PCA  was examined.  Addition  of 30 mM  EDTA  to a  reaction mixture of stimulated 
cell  homogenate,  a~SI-prothrombin,  and  calcium  prevented  cleavage  (Fig.  1,  top 
panel).  This  inhibition  could  be  abrogated  by  the  addition  of additional  calcium 
(data not shown). 
To  determine  the protease characteristic of the monocyte  prothrombinase,  cellular 
homogenates  from  Ag/Ab-  or  LPS-stimulated  PBM  were  first  incubated  with serial 
concentrations  of DFP.  After  15  min  at  22°C,  125I-prothrombin  and  calcium  were 
added  and  incubated  for  30  min  at  37°C.  The  effect  of  DFP  on  the  cleavage  of 
prothrombin  is illustrated in Fig.  2. DFP  at 2.5 mM  or higher prevented  the cleavage 1470  INDUCIBLE MONOCYTE  PROTHROMBINASE 
Fio. 2.  Inhibition of inducible prothrombinase of murine monocytes by DFP. Homogenates of 
1 ×  l0  s Ag/Ab-stimulated PBM  in 0.5  ml TBS were incubated for  15  rain at  22°(] with the 
indicated concentration of DFP. To 0.05 ml of each reaction was added 0.01 ml ~I-prothrombin 
(100 mM) and 0.01 ml (]a(]12 (25 raM) for 30 rain at 37°C. SDS and EDTA were then added, and 
the samples eleetrophoresed on a SDS-10% polyaerylamide slab gel and displayed by autoradiog- 
raphy. Lane 1: l~SI-prothrombin,  (]aCl2, TBS. Lanes 2-7: laSI-prothrombin,  (]aCl2, prothrombinase 
containing cell homogenates that had been incubated with 10, 2.5, 1.0, 0.62, 0.16, and 0.04 mM 
DFP, respectively. 
=- ~  40 
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Fro.  3.  Appearance of prothrombinase in murine PBM with increasing times of exposure to Ag/ 
Ah or LPS. PBM at tO  e in  1 ml complete medium were incubated at 37°(] for increasing times in 
the presence of 100/~g/ml soluble Ag/Ab  (Q)  or  t0/~g/ml LPS (AIL). At the times indicated, cells 
were washed twice in  1 ml and resuspended  in 0.5 ml TBS. After disruption, cellular homogenates 
were combined with a2SI-prothrombln and (]a(]12 for 30 rain at 37°(], and the reactions analyzed for 
12SI-prothromhin cleavage by SDS-PAGE and autoradiographic display. 
of prothrombin, whereas  at  1 mM  or  less  no  inhibition was  observed.  This effect 
differed from that of factor Xa, because 10 mM DFP was required to inhibit factor 
Xa in the presence of unstimulated cellular homogenates. 
Membrane-associated Monocyte Prothrombinase.  The prothrombinase activity of PBM 
progressively increased between 2 and 6 h  after exposure to stimuli. Maximum levels 
of prothrombinase activity were expressed by PBM after 5  h  exposure to LPS, and 
after 6 h  incubation with Ag/Ab (Fig. 3). Simultaneous exposure of cells in culture to 
both LPS  and Ag/Ab did not further increase PCA  (1,620  mU/106 cells)  to levels 
greater than exposure to either LPS  (1,590 mU/106 cells) or Ag/Ab (1,650 mU/106 SCHWARTZ, LEVY,  FAIR, AND  EDGINGTON  1471 
cells) alone, indicating a nonadditive response and suggesting a quantitatively limiting 
step. 
We have previously shown  (14,  15)  cells of the monocyte/macrophage cell lineage 
to  be  the origin of collaboratively induced  PCA.  In  the present  study,  PBM  were 
separated by adherence  into  monocytes  and  lymphocytes.  Prothrombinase  activity 
was observed in the monocyte population in contrast to its absence in lymphocytes 
(Table IV). Whereas lymphocytes have been shown  to be necessary for induction of 
murine monocyte PCA by LPS or Ag/Ab  (14,  15), the effect of lymphocytes on the 
expression of monocyte prothrombinase, once it had been induced, has not previously 
been examined and was tested. Homogenates of 5  ×  105 monocytes from Ag/Ab or 
LPS triggered PBM-induced fibrin formation in reaction mixtures of only prothrom- 
bin, fibrinogen, and CaCI2 in 33 +  2 s in the absence or presence of 0.5,  1, 2, or 4  X 
106 lymphocytes, indicating that lymphocytes do not influence the functional activity 
of this monocyte product once produced. 
Partial subcellular localization of the enzymatic activity was carried out  by frac- 
tionation of 107 induced or control monocytes. After disruption and sedimentation of 
nuclei, the cytosol fraction (1 h at  100,000 g supernatant) was devoid of prothrombin- 
cleaving  activity  (<5%  l~I-prothrombin  cleaved),  whereas  the  membrane/micro- 
organelle pellet, when  resuspended in the original volume of TBS, contained potent 
prothrombinase activity (>97% 12SI-prothrombin cleaved). 
The amount  of prothrombin-cleaving activity was found to be related in a  linear 
fashion to the number of Ag/Ab or LPS induced monocytes present in the assay, x2~I- 
prothrombin cleavage (Fig. 4)  was marginally increased after 30  min  at  37°C  with 
TABLE  IV 
Prothrombinase Activity  of Cell Populations  from LPS- or Ag/Ab-stimulated 
Murine PBM 
Clotting time 10  6 cells  Percent a2sI- 
Stimulated cell  Purified  prothrombin 
population*  Normal human  cleaved/10  6 
plasma:~  compo-  cellsl[ 
nents§ 
s/mU  s 
PBM  31/1,420  51  58 
Lymphocytes  85/27  420  3 
Monocytes  21/8,200  27  98 
* 106 PBM in  1 ml complete medium  incubated with  10 #g/ml LPS or 100 
#g/ml Ag/Ab for the final 6 h of separation.  After separation,  cells were 
washed  twice in  1 ml TBS,  resuspended  in  0.5  ml TBS,  disrupted, and 
assayed for prothrombin  cleaving activity. 
One-stage plasma recalcification test using 0.1  ml normal  human plasma, 
0.1 ml test sample, and 0.1 ml 25 mM CaCI2, combined at 37°C, and the 
time required for fibrin clot formation recorded. 
§ One-stage clotting assay: 0.05 ml fibrinogen (4.0 mg/ml), 0.05 ml prothrom- 
bin (160 p.g/ml), 0.1 ml test sample, and 0.1  ml CaClz were combined at 
37°C, and the time required for fibrin clot formation recorded. 
II Cleavage was determined  after 0.01 ml of Iz~I-prothrombin (100 nM)  was 
incubated with 0.01 ml 25 mM CaCIz and 0.05 ml test sample at 37 ° for 30 
min. Reactions were stopped by addition of SDS and EDTA, and applied to 
a  1% SDS-10% polyacrylamide slab gel. After electrophoresis, fixing, and 
drying,  autoradiography was performed  and percent  cleavage of 12Sl-pro- 
thrombin determined by densitometry. 1472  INDUCIBLE  MONOCYTE  PROTHROMBINASE 
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FIC.  4.  Cleavage  of 125I-prothrombin  by differing numbers of prothrombinase-positive murine 
monocytes. Murine PBM were incubated with Ag/Ab or LPS for 6 h, after which the cells were 
separated by adherence. Monocytes were disrupted, and 0.05 ml of celt homogenate was combined 
with 0.01 ml of 100 nM 125I-prothrombin  (0.045 potential U of thrombin), 0.2 U hirudin in 0.01 ml, 
and 0.01  ml of 25  mM CaCI2  for 30 min at 37 °.  Reactions were analyzed for a25I-prothrombin 
cleavage by SDS-PAGE, autoradiography, and soft laser densitometry. 
30 
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FxG.  5.  Kinetics of 12~I-prothrombin  cleavage by  106 murine Ag/Ab- or LPS-stimulated  PBM. 
Homogenates of  106  stimulated  PBM  (0.05  ml)  were  incubated with 0.01  ml  of  100  nM  125I- 
prothrombin, 0.2  U  hirudin  in 0.01 ml,  and 0.01  ml  of 25  mM  CaCI2  at  37°C.  At  the  times 
indicated, the reactions were stopped by the addition of EDTA and SDS, and the samples subjected 
to SDS-PAGE and autoradiographic analysis. 
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Fxo.  6.  Influence of pH  on proteolytic activity of inducible murine monocyte prothrombinase. 
Homogenates of 106 PBM/ml were prepared in Hepes-buffered saline at pH 6.0, 6.5, 7.0, 7.5, or 8.0. 
Aliquots (0.04 ml) were incubated for 30 min at 37 ° with 0.01 ml of 25 mM CaCte (in appropriate 
pH buffer) and 0.01  ml 125I-prothrombin.  At the end of incubation, before addition of SDS and 
EDTA, the pH of each reaction was confirmed. 125I-prothrombin  cleavage was determined by SDS- 
PAGE and autoradiographic analysis. 
homogenate  from  1  X  103  PCA-positive  monocytes.  Under  identical  conditions,  a 
progressive and  linear increase  in prothrombin  cleavage was observed with logarith- 
mically increasing numbers  of cells up to 107 monocytes. The dose-effect was consistent 
with a  first order reaction. 
The  kinetics of prothrombin  cleavage  by  106  stimulated  PBM  were  examined  in 
the  presence  of  hirudin  to  inhibit  thrombin-  (generated  by  action  of  PCA  on 
prothrombin)  mediated  cleavages of the prothrombin  substrate,  a  secondary  in vitro 
proteolytic consequence of prothrombin  activation. PCA-induced  PBM  were washed, 
disrupted,  and homogenate  equivalent  to  l0  s cells was incubated  with 125I-prothrom- 
bin and CaC12. At various times, samples were removed, the reaction terminated  with SCHWARTZ,  LEVY, FAIR, AND EDGINGTON  1473 
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Flo.  7.  Temperature dependence  of the inducible murine  monocyte prothrombinase. Homoge- 
natcs of 106 stimulated PBM/ml in TBS were prepared; and 0.04 ml aliquots of homogenate,  0.01 
m] of 100 nM l~I-prothrombin, and 0.0] m] of 25 mM CaCI2 were incubated for 30 min at 4  °, 1,5  °, 
22  °, 37  °, 50  °, or 70°C. The reactions were terminated with EDTA and SDS, and analyzed for l~sI- 
prothrombin cleavage by SDS-PAGE and autoradiography. 
TABLE  V 
Murine Monocytes Do Not Possess a Preexisting Inhibitor or Zymogen of 
Inducible Prothrombinase Activity 
Number  of unstimulated 
PBM  added to  1 x  10  6 
PBM  possessing pro- 
thrombinase activity* 
Percent  Percent augmentation 
125i_prothrombi  n  (+) or inhibition (-) of 
cleavage:~  12SI-prothrombin  cleav- 
age 
0  46  -- 
1 ×  106  43  -6.5 
2  ×  106  50  +8.7 
3  ×  106  43  --6.5 
4  ×  10  6  48  +4.4 
* 1 ×  10  s PBM/ml, which had been incubated with 100 p.g Ag/Ab or 10 p,g 
LPS, were shown to possess prothrombinase activity and were combined 
with varying numbers of basal unstimulated cells in a final volume of 1 ml 
of TBS for 15 min at 22°C, then disrupted by freeze-thaw sonication before 
assay for 125I-prothrombin  cleavage, as described in Materials and Methods. 
~:Cell homogenate (0.025 ml), l~I-prothrombin  (0.01 ml of 100 nM), and 
CaCI2 (0.01 ml of 25 mM) were incubated at 37°C for 30 min. EDTA and 
SDS were added, and the samples analyzed for ~2SI-prothrombin  cleavage by 
SDS-PAGE, autoradiography, and laser densitometry. 
SDS  and EDTA, and the  extent of cleavage characterized  by SDS-PAGE  (Fig.  5). 
There  was  an  apparent  5  10  min  initial lag  period  followed  by  a  linear rate  of 
prothrombin cleavage to 60 min, when >90% of the substrate was consumed. This lag 
period  could  be  eliminated if the  number of  PCA-induced PBM  present  in  the 
incubation mixture was increased to  107 (data not shown). 
The monocyte membrane prothrombinase induced by Ag/Ab or LPS was further 
analyzed for pH and thermal optima. As seen in Fig. 6, the inducible prothrombinase 
recovered in cellular homogenates cleaved optimally at pH 6.7-7.6. Maximal cleavage 
was observed at the thermal optimum of 37°C (Fig. 7). 
Inhibitor or Zymogen Forms of the Enzyme.  The possibility that the induction of PCA 
in murine monocytes results in the inactivation of a coexisting inhibitor, or activation 
of a zymogen form of the prothrombinase was explored. A constant number (1  ×  106) 
of LPS- or Ag/Ab-induced PBM were combined with 0-4 ×  106 unstimulated PBM 
in 1.0 ml of TBS. The latter cells serve as a  source of putative inhibitor or zymogen. 
The  cell  mixtures  were  disrupted  and  assayed  for  prothrombin  cleaving activity 
(Table V). The lack of effect of the added unstimulated cells indicates that they lack 1474  INDUCIBLE  MONOCYTE  PROTHROMBINASE 
an inhibitor, thus excluding the hypothesis that the increase of PCA after stimulation 
results from a reduction in concentration of an inhibitor. Similarly, the unstimulated 
cells  would  have  provided  additional  zymogen with  an  increase  of activity  if the 
induction event represented the production of an enzyme that cleaved the prothrom- 
bin zymogen to active prothrombinase, or if the prothrombinase was autoactivating. 
Because this was not observed, we conclude that  the appearance of prothrombinase 
activity probably represents synthesis of new enzyme molecules. 
Plasminogen-activator  Activity.  Homogenates  of  1,  2,  3,  4,  6,  or  8  ×  106  PBM 
stimulated with small soluble Ag/Ab  (4:1  ratio)  for 6  h  were prepared in 0.5  ml of 
TBS and assayed for plasminogen-activator activity. The addition of cellular homog- 
enates of stimulated PBM to the plasminogen and radioiodinated fibrin led to release 
of no more radioactivity (217 __. 17 CPM) than did wells containing TBS, plasminogen, 
and 125I-fibrin alone (208 +  26 cpm). 
Discussion 
The rapid collaborative PCA response of murine splenic mononuclear cells to LPS 
has  been  recently characterized  (14).  A  PCA  response  is  also observed  for murine 
PBM  exposed  to soluble Ag/Ab  or LPS  (15).  In these  studies,  the  macrophage or 
monocyte, respectively, was identified as the cellular source of PCA and the collabo- 
rative requirement for intact viable lymphocytes was established. 
In the present study we describe and characterize this murine monocyte PCA as an 
inducible prothrombinase, a new pathway of recruitment of the coagulation pathways. 
In experiments using plasmas deficient in coagulation  factors XII, VIII, VII, X, V, 
and II (prothrombin), only the latter failed to support fibrin formation in the presence 
of the cellular PCA;  addition  of purified prothrombin to factor II-deficient plasma 
restored  the  ability of this  plasma to serve as substrate  for the  cellular  PCA.  The 
inducible  PCA  thus  exerted  its  effect  through  neither  the  classical  intrinsic  nor 
extrinsic  procoagulatant  activation  cascades  (34),  but  rather  by  direct  action  on 
prothrombin in the late stage of coagulation. 
To substantiate this unanticipated prothrombinase-like activity, prothrombin was 
incubated with homogenates of stimulated or unstimulated PBM  in the presence of 
calcium,  and  the  products of this  reaction  were analyzed.  12SI-prothrombin, which 
had been incubated with unstimulated PBM, remained intact by SDS-PAGE. How- 
ever, the addition of PCA-positive PBM to 125I-prothrombin resulted in prothrombin 
cleavage  to  lower-molecular  weight  products  comparable  to  those  resulting  from 
cleavage by purified factor Xa and included thrombin per se or an indistinguishable 
product. This was not the result of thrombin contamination or secondary cleavage of 
prothrombin by generated thrombin, because identical cleavage was observed in the 
presence  of hirudin,  a  rapid  and  potent  inhibitor  of thrombin.  The  thrombinlike 
product of the PCA action on prothrombin efficiently converted purified fibrinogen 
to fibrin, whereas PCA positive cellular homogenates did not directly cleave fibrinogen 
or convert it to fibrin. Thus, the evidence suggests the inducible PCA acts by directly 
cleaving  prothrombin  to  an  active  thrombinlike  enzyme,  if not  thrombin  per  se, 
capable of inducing the fibrinogen-fibrin transformation. 
Monocytes are the source of the induced prothrombinase and require the presence 
of intact  stimulus-triggered  lymphocytes  for  prothrombinase  induction.  However, 
once  induced,  the  presence  of  lymphocytes  was  without  effect  on  the  product. SCHWARTZ, LEVY, FAIR, AND EDGINGTON  1475 
Prothrombinase was not detectable in  10  7 freshly isolated murine monocytes, but was 
demonstrable in as few as  103 monocytes that had been incubated with lymphocytes 
and  stimulated  with  soluble Ag/Ab  or  LPS.  This  represents at  least  a  10,000-fold 
increase in monocyte prothrombinase. The prothrombinase did not appear to result 
from uptake of serum factors by ceils in culture, insofar as full prothrombinase activity 
was observed in thoroughly washed cells cultured in the absence of serum. 
Inducible lymphoid PCA is apparently expressed at the surface of viable peripheral 
monocytes and splenic macrophages, because viable ceils induce coagulation (14,  15). 
We observed surface expression of prothrombinase  activity in  the present  study as 
well. In agreement with our previous studies (14,  15), we found by the more definitive 
prothrombin cleavage assay that surface expression of PCA was no more than 20% of 
the  total  cellular  content.  Partial  subcellular  fractionation  by  ultracentrifugation 
localized the prothrombinase to the crude membrane/small organelle fraction. The 
active prothrombinase is not released or secreted into the medium. As such, monocyte 
prothrombinase appeared to be the major form of murine lymphoid PCA previously 
described  (14,  15)  for the  response  to  LPS  and  Ag/Ab.  This  differs  from  human 
lymphoid cells, which respond to the same stimuli by production of tissue factor, the 
activator of the extrinsic coagulation pathway (35).  It should be noted, however, that 
human monocytes can be induced to produce a  prothrombinase by certain subfrac- 
tions  of plasma lipoproteins  (28),  a  response  that,  although  nonimmunologic,  also 
requires lymphocyte collaboration (36). 
The inducible murine monocyte prothrombinase has characteristics consistent with 
a serine protease, i.e., inhibition by DFP. Indeed, the concentration of DFP required 
for enzyme inhibition was well within the range required by a  number of the serine 
proteases of the coagulation cascade (37). Notably, the monocyte prothrombinase was 
more sensitive to DFP than  factor Xa, the classical prothrombinase. The monocyte 
prothrombinase required the presence of calcium to cleave prothrombin. However, it 
is  not  clear whether  this  calcium  requirement  was  for the  prothrombinase  or  the 
prothrombin substrate.  Prothrombin must bind calcium via its gamma-carboxyglu- 
tamic acid residues to undergo requisite conformational transitions and then bind to 
phospholipid to render appropriate domains susceptible to proteolysis (38). Whether 
there are similar types of requirements for the prothrombinase remains to be investi- 
gated.  The cleavage of prothrombin  substrate  was  linear  with  time,  and  cleavage 
increased linearly in proportion to the log concentration of induced monocytes. Both 
data suggest a direct first-order proteolytic event exhibiting no cooperative effects. 
A  number  of possible  mechanisms  might  account  for  the  present  observations. 
Triggered  lymphocytes could  induce  monocyte  PCA by:  (a)  inducing  synthesis of 
active prothrombinase; (b) suppressing synthesis of a prothrombinase inhibitor; or (c) 
induction  of a  protease  that  converts  a  zymogen  to  the  active  prothrombinase. 
Unstimulated  cell homogenates were added as a  source of hypothetical inhibitor or 
zymogen to stimulated  PBM cell homogenates and did not  modify prothrombinase 
activity. From this we conclude that unstimulated cells do not contain an inhibitor to 
the prothrombin activator or a zymogen of the prothrombinase analogous to proteases 
of the coagulation cascade present in plasma in the zymogen form (34,  37). Thus, the 
most  reasonable  postulate  is  that  LPS-  or  Ag/Ab-triggered  murine  lymphocytes 
induce I-A-compatible monocytes (16)  to synthesize the active prothrombinase. 
Mononuclear phagocytes serve an important role in tissue inflammation and repair. 1476  INDUCIBLE MONOCYTE  PROTHROMBINASE 
Some macromolecular products of monocytes or macrophages can be assigned roles 
in inflammatory lesions. Collagenase, inducible by phagocytosis (8), and elastase, also 
inducible  (9),  have recognizable functions in inflammation (39).  Plasminogen acti- 
vators (19) are induced by soluble products of stimulated lymphocytes (40) and serve 
as markers of macrophage activation (2). The inducible monocyte prothrombinase is 
not a  plasminogen activator;  but  the relationship to some other monocyte neutral 
proteases has not been explored. The possibility that the monocyte prothrombinase 
could  be  factor Xa  has  been  examined  for human  cells  (28),  and  appears  to  be 
incorrect. Limited evidence suggests that murine macrophages cultured in vitro might 
produce  factor X  (41).  However,  the  murine  monocyte prothrombinase  does  not 
appear  to  be  factor  Xa  based  on  susceptibility  to  inhibitors,  molecular  weight, 
prothrombin cleavage products, and lack of factor Va cofactor amplification (B. S. 
Schwartz, D. S. Fair, and T. S. Edgington, manuscript in preparation). 
The synthesis by specifically induced monocytes of an activator of the coagulation 
pathway is consistent with fibrin deposition in  inflammatory tissue lesions.  Fibrin 
formation per se is  responsible  for the  induration of delayed-type hypersensitivity 
reactions (13), in which monocytes are major effector cells. Human monocytes in the 
presence of lymphocytes respond  to  LPS or Ag/Ab  by generating tissue factor or 
comparable procoagulant molecules (17,  18). In contrast, human monocytes respond 
to lymphocytes triggered by certain density classes of human plasma lipoproteins by 
expression  of a  prothrombinase  (28,  36).  The  present  description  of an  inducible 
murine  monocyte prothrombinase  provides  a  mechanism  for direct  generation  of 
thrombin or a thrombinlike activity at inflammatory sites. This product clots fibrin- 
ogen; whether these prothrombin products are also capable of activating factors V 
(42) and VIII (43) and stimulating platelets (44), as well as fulfilling other functions 
of thrombin (45, 46)  remains to be examined. Further insight to possible molecular 
mechanisms of interactions between components of the coagulation process and the 
immune system have been forthcoming from the studies of Geczy and Hopper (47) 
and Hopper et al.  (48).  Inhibition of guinea pig peritoneal macrophage migration 
correlated with lymphokine-dependent macrophage production of a tissue factorlike 
activity. These investigations have proposed that lymphokine-induced inhibition of 
peritoneal  macrophage  migration  may  be  mediated  by  fibrin  formation  on  the 
macrophage surface. The  presence  of a  prothrombinase on  the surface of murine 
monocytes provides a direct mechanism for such fibrin formation. 
Summary 
Murine lymphoid cells respond rapidly to bacterial lipopolysaccharide or antigen- 
antibody complexes to initiate or accelerate the blood coagulation pathways. The 
monocyte or macrophage has been identified as the cellular source, although lympho- 
cyte collaboration is required for the rapid induction of the procoagulant response. 
This procoagulant activity is identified in the present study as a direct prothrombin 
activator, i.e., a prothrombinase. Studies with plasmas deficient in single coagulation 
factors demonstrate that the induced murine procoagulant activity effector molecule 
does not require  factors XII, VIII, VII, X, or V, but does require prothrombin to 
transform fibrinogen to fibrin. This enzyme(s) produces limited proteolysis of pro- 
thrombin to yield thrombin or thrombinlike products that are functionally capable of 
converting fibrinogen to fibrin. The prothrombinase is undetectable in freshly isolated SCHWARTZ, LEVY, FAIR, AND EDGINGTON  1477 
murine peripheral blood mononuclear cells,  but increases to maximal levels  within 6 
h  after cells  are exposed to bacterial lipopolysaccharide or soluble antigen/antibody 
complexes. Induced monocytes express the prothrombinase on their surface; however, 
the  activity is  increased  fivefold by cellular  disruption  indicating a  predominantly 
intracellular pool of enzyme. The prothrombinase is not secreted into the medium in 
an  active  form  but  is  recovered  with  the  cell  membranes  and  small  organelles. 
Cleavage of prothrombin by the monocyte prothrombinase requires the presence of 
calcium and  is inhibited  by 2.5  mM diisopropylfluorophosphate, suggesting that  it 
may be a  serine protease.  Enzymatic activity is proportional to the concentration of 
monocytes, and the pH and thermal optima are in the physiologic range. This neutral 
protease  exhibits  first-order  kinetics,  and  the  cleavage  of  prothrombin  increases 
linearly with  time.  Induction of activity appears most likely due to newly initiated 
synthesis of the enzyme per se rather than neutralization of an inhibitor or activation 
of a  zymogen. Monocytes induced  to express  prothrombinase by this collaborative 
pathway  are  not  induced  to  express  plasminogen  activator.  We  propose  that  this 
procoagulant  effector  molecule  or  monokine  may  be  responsible  for  local  fibrin 
deposition  observed at  sites  of lipopolysaccharide- and  antigen/antibody complex- 
induced  inflammation and  may contribute to the  histogenesis  and  pathogenesis of 
these and certain other immunologically mediated tissue lesions. 
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